Amlodipine And Valsartan
NDC 45865-890
Product Information
Amlodipine And Valsartan is a ANDA-approved product labeled by Medsource Pharmaceuticals. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a yellow product. This product entry covers the primary NDC 45865-890 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
L;37
Code Structure Chart
Product Details
What is NDC 45865-890?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- AMLODIPINE BESYLATE (UNII: 864V2Q084H)
- AMLODIPINE (UNII: 1J444QC288) (Active Moiety)
- VALSARTAN (UNII: 80M03YXJ7I)
- VALSARTAN (UNII: 80M03YXJ7I) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- POVIDONE K30 (UNII: U725QWY32X)
- STARCH, CORN (UNII: O8232NY3SJ)
- SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)
- FERRIC OXIDE RED (UNII: 1K09F3G675)
- HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
- POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P)
- TALC (UNII: 7SEV7J4R1U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 722137 - amLODIPine 5 MG / valsartan 320 MG Oral Tablet
- RxCUI: 722137 - amlodipine 5 MG / valsartan 320 MG Oral Tablet
- RxCUI: 722137 - amlodipine (as amlodipine besylate) 5 MG / valsartan 320 MG Oral Tablet
* Please review the full disclaimer at the bottom of this page.